# OnCo record golcadomide (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/golcadomide/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "golcadomide" ;
  schema:name "Golcadomide"@en ;
  schema:description "Golcadomide is a next-generation lenalidomide-like pill that degrades two lymphoma transcription factors far more potently, now in phase 3 with R-CHOP."@en ;
  schema:url <https://onco.cc/drugs/golcadomide/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06356129> ;
  onco:status "phase-3" ;
  onco:modality "Molecular glue degrader (CELMoD, IKZF1/3)" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/> ;
  onco:targets <https://onco.cc/targets/ikzf1/>, <https://onco.cc/targets/ikzf3/> ;
  onco:companies <https://onco.cc/companies/bms/> ;
  onco:trials <https://onco.cc/trials/golseek-1/>, <https://onco.cc/trials/nct06911502/>, <https://onco.cc/trials/nct06090539/>, <https://onco.cc/trials/nct03930953/>, <https://onco.cc/trials/nct06425302/> .